Clinical Trials · NCT07676331
Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Enrollment
- 168
- Start date
- Aug 2026
- Locations
- See registry
- Primary endpoint
- Ki67 proliferation marker